scholarly article | Q13442814 |
P356 | DOI | 10.1111/VCP.12255 |
P8608 | Fatcat ID | release_44fwc2ypfbharb4fufqdinsfpi |
P698 | PubMed publication ID | 25866911 |
P2093 | author name string | Stephan Neumann | |
Julia Schüttler | |||
P2860 | cites work | Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 |
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis | Q33980630 | ||
Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. | Q34047262 | ||
Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis | Q34086518 | ||
Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis--a prospective, observational study | Q34582422 | ||
C-reactive protein in end-stage renal disease: are there reasons to measure it? | Q35997686 | ||
The Role of IL-6, 8, and 10, sTNFr, CRP, and Pancreatic Elastase in the Prediction of Systemic Complications in Patients with Acute Pancreatitis | Q36641146 | ||
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer | Q37080407 | ||
Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. | Q40476434 | ||
Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis | Q40700521 | ||
Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain | Q43498366 | ||
Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy. | Q46822230 | ||
Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock | Q50978969 | ||
Plasma interleukin-6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. | Q52923669 | ||
Effects of T lymphocytes, interleukin-1, and interleukin-6 on renal fibrosis in canine end-stage renal disease. | Q53814834 | ||
Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes | Q58681842 | ||
P433 | issue | 2 | |
P304 | page(s) | 223-228 | |
P577 | publication date | 2015-04-13 | |
P1433 | published in | Veterinary Clinical Pathology | Q15755330 |
P1476 | title | Interleukin-6 as a prognostic marker in dogs in an intensive care unit | |
P478 | volume | 44 |
Q46143764 | Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection during treatment with the 2014 American Heartworm Society recommended treatment protocol |
Q47792494 | Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection treated using the slow kill method |
Q54942768 | Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease. |
Q35903848 | Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis. |
Q47234412 | Serum alpha1 -proteinase inhibitor concentrations in dogs with systemic inflammatory response syndrome or sepsis |
Q40664877 | Serum interleukin-6 as a prognostic marker in neonatal calf diarrhea |
Q64447787 | The effect of ammonia on canine polymorphonuclear cells |
Q47135939 | Treatment with 24 h-delayed normo- and hyperbaric oxygenation in severe sepsis induced by cecal ligation and puncture in rats |
Search more.